An international team of scientists has achieved a breakthrough in biomedicine by obtaining fully functional hair follicles under laboratory conditions. The achievement, described in the prestigious journal 'Nature', involves developing a method that uses stem cells to create a follicle capable of producing hair. Although the technique is still in the early stages of preclinical research, it offers real hope for future therapies treating hair loss and other conditions related to hair loss. Scientists emphasize that this is the first instance of creating a structure capable of the natural hair growth cycle. This success opens new possibilities in the fields of regenerative medicine and tissue engineering.

First Functional Follicles

For the first time, scientists have managed to grow hair follicles under laboratory conditions that are fully functional, meaning they are capable of producing hair and undergoing its natural growth cycle. This is a key achievement in the field of tissue engineering.

Stem Cell-Based Method

The breakthrough technique is based on the use of stem cells, which are appropriately stimulated and organized into three-dimensional structures in a special bioreactor. This process mimics the natural stages of hair follicle development in the body.

Hope for Hair Loss Treatment

The achievement offers immense hope for millions of people worldwide suffering from various forms of hair loss, including androgenetic alopecia, scarring alopecia, or that resulting from autoimmune diseases. It could lead to the development of effective therapies to replace transplants.

Long Road to the Clinic

Despite the success, the path to a potential therapy available to patients is still long. Further advanced preclinical and clinical research is necessary to confirm the safety, effectiveness, and durability of hair follicles created in this way.

Scientists have made a groundbreaking discovery in the field of regenerative medicine, for the first time obtaining fully functional hair follicles under laboratory conditions. This achievement, published in the prestigious journal 'Nature', involves developing a method that uses stem cells to create a follicle capable of producing hair and undergoing its natural growth cycle. The technique, the result of work by an international team of researchers, addresses one of the greatest challenges in tissue engineering – recreating complex, miniature organs such as hair follicles. Attempts to grow hair and its bulbs in the laboratory have been ongoing for decades, encountering fundamental difficulties related to recreating the complex, three-dimensional structure of the follicle and its interaction with the surrounding skin. Previous methods often allowed for the creation of only simplified, dysfunctional structures lacking the ability for proper growth. The key to success turned out to be precise control of the stem cell microenvironment in a special bioreactor. This allowed the cells to self-organize into three-dimensional structures, mimicking the natural process of embryogenesis, i.e., the formation of hair follicles in an embryo. The organoids created in this way not only had all the characteristic cell layers of a real follicle but were also innervated and vascularized, which is essential for their long-term function. „This is the first time anyone has made fully functional hair follicles from scratch in a lab that show natural cycling and can produce hair long term.” — Lead researcher 3 mm — Length of hair grown in the laboratory The discovery has colossal significance for the development of new anti-hair loss therapies. Current methods, such as hair transplants from the back of the head (FUT or FUE technique), have limitations – they rely on redistributing existing follicles, not creating new ones. The breakthrough laboratory technique could theoretically provide an unlimited number of new, fully functional follicles for patients with androgenetic alopecia (male and female), alopecia areata, as well as for people with hair loss after burns or injuries causing scarring. Despite the enormous potential, scientists are cautious in their forecasts. The path from a promising laboratory experiment to an approved clinical therapy is long, costly, and requires confirmation of safety and long-term effectiveness in humans. The next step will be process optimization and tests on model animals.